Elevance Health, Inc.
ELVElevance Health, Inc. (ELV), formerly known as Anthem, Inc., is a leading health benefits company that provides a range of health insurance products and services. Based in the United States, it offers medical, dental, vision, and pharmacy plans, as well as related administrative services. The company serves individuals, employers, and government programs, and is recognized for its commitment to improving health outcomes and innovative healthcare solutions.
Dividend History
Investors can expect a dividend payout of $1.72 per share, scheduled to be distributed in 69 days on September 25, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 25, 2026 | $1.72 | 2026-09-10 | 2026-09-10 |
| June 25, 2026 | $1.72 | 2026-06-10 | 2026-06-10 |
| March 25, 2026 | $1.72 | 2026-03-10 | 2026-03-10 |
| December 19, 2025 | $1.71 | 2025-12-05 | 2025-12-05 |
| September 25, 2025 | $1.71 | 2025-09-10 | 2025-09-10 |
Dividends Summary
- Consistent Payer: Elevance Health, Inc. has rewarded shareholders with 71 dividend payments over the past 19 years.
- Total Returned Value: Investors who held ELV shares during this period received a total of $61.81 per share in dividend income.
- Latest Payout: The most recent dividend of $1.72/share was paid 23 days ago, on June 25, 2026.
- Yield & Schedule: ELV currently pays dividends quarterly with an annual yield of 1.84%.
- Dividend Growth: Since 2007, the dividend payout has grown by 215.2%, from $0.55 to $1.72.
- Dividend Reliability: ELV has maintained or increased its dividend for 63 consecutive payments.
Company News
Kirby McInerney LLP is investigating potential securities law violations by Elevance Health, Inc. after the Centers for Medicare & Medicaid Services notified the company of intent to impose intermediate sanctions, including suspension of Medicare Advantage enrollment and communication activities due to alleged noncompliance with risk adjustment d...
Elevance Health reported Q1 2026 adjusted earnings of $12.58 per share, beating consensus of $10.79, with revenues of $49.49 billion up 1.5% YoY. The company raised its 2026 earnings guidance to at least $26.75 per share from $25.50, though margins were pressured by elevated medical costs in Medicaid and a $935 million CMS-related accrual. Stock ...
The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing great...
Johnson Fistel is investigating Elevance Health, Inc. following the company's disclosure that the Centers for Medicare & Medicaid Services intends to impose intermediate sanctions, including suspension of enrollment into certain Medicare Advantage-Prescription Drug plans effective March 31, 2026. The law firm is examining whether Elevance and its...
Elevance Health (ELV) stock declined 7.23% on Monday after the Centers for Medicare & Medicaid Services (CMS) froze the company's Medicare Advantage enrollment effective March 31, 2026. The freeze stems from alleged noncompliance with risk adjustment data submission requirements, including the company's repeated use of USB drives instead of CMS-m...
